Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.46 |
| ▸ | PGK2 | P07205 | 1/20 | 0.46 |
| ▸ | FDPS | P14324 | 5/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31429819 | 0.76 | FDPS (0.37) | PGK1PGK2FDPSP2RX7 | |
| Phosphoric Acid SCHEMBL459067 | 0.75 | FDPS (0.38) | PGK1PGK2FDPSP2RX7 | |
| Phosphoric Acid SCHEMBL938025 | 0.75 | FDPS (0.38) | PGK1PGK2FDPSP2RX7 | |
| Phosphoric Acid SCHEMBL28969998 | 0.73 | FDPS (0.37) | FDPSP2RX7 | |
| SCHEMBL4543554 | 0.73 | PGK1 (0.41) | PGK1PGK2SMN1; SMN2 | |
| Pyridin-2-Ylmethylphosphonic Acid SCHEMBL31467550 | 0.73 | FDPS (0.65) | PGK1PGK2FDPSSMN1; SMN2 | |
| Pyridin-2-Ylmethylphosphonic Acid SCHEMBL1585351 | 0.73 | FDPS (0.65) | PGK1PGK2FDPSSMN1; SMN2 | |
| Pyridin-2-Ylmethylphosphonic Acid SCHEMBL1584747 | 0.72 | FDPS (0.62) | PGK1PGK2FDPSSMN1; SMN2 | |
| Pyridin-2-Ylmethylphosphonic Acid SCHEMBL1584752 | 0.72 | FDPS (0.62) | PGK1PGK2FDPSSMN1; SMN2 | |
| SCHEMBL8905757 | 0.72 | GAA (0.39) | FDPSP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1261630-A2 | BACTERIAL GENES AND PROTEINS THAT ARE ESSENTIAL FOR CELL VIABILITY AND THEIR USES | Bristol-Myers Squibb Company (US) | 2002-12-04 | — | — | EP | claimed |
| WO-2001049721-A2 | BACTERIAL GENES AND PROTEINS THAT ARE ESSENTIAL FOR CELL VIABILITY AND THEIR USES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-07-12 | — | — | WO | claimed |
| US-20250295749-A1 | INACTIVATED STAPHYLOCOCCUS COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | BIOLOGICAL MIMETICS INC (US) | 2025-09-25 | — | — | US | disclosed |
| US-20250188507-A1 | FOOD COMPOSITIONS COMPRISING RECOMBINANT MILK PROTEINS | Nobell Foods, Inc. | 2025-06-12 | — | — | US | disclosed |
| US-12241109-B2 | Host cells comprising a recombinant casein protein and a recombinant kinase protein | Nobell Foods, Inc. (US) | 2025-03-04 | — | — | US | disclosed |
| US-20250029674-A1 | COMPOSITIONS AND METHODS FOR EXPRESSING GENES OF INTEREST IN HOST CELLS | Nobell Foods, Inc. | 2025-01-23 | — | — | US | disclosed |
| US-20250011828-A1 | HOST CELLS COMPRISING A RECOMBINANT CASEIN PROTEIN AND A RECOMBINANT KINASE PROTEIN | Nobell Foods, Inc. (US) | 2025-01-09 | — | — | US | disclosed |
| US-12148506-B2 | Compositions and methods for expressing genes of interest in host cells | Nobell Foods, Inc. (US) | 2024-11-19 | — | — | US | disclosed |
| US-12139737-B2 | Host cells comprising a recombinant casein protein and a recombinant kinase protein | Nobell Foods, Inc. (US) | 2024-11-12 | — | — | US | disclosed |
| US-12077798-B2 | Food compositions comprising recombinant milk proteins | Nobell Foods, Inc. (US) | 2024-09-03 | — | — | US | disclosed |
| US-20240251810-A1 | INCREASED YIELD OF MILK PROTEIN PER ACRE | Nobell Foods, Inc. | 2024-08-01 | — | — | US | disclosed |
| US-20060063224-A1 | Method for the identification and treatment of pathogenic microorganism infections by inhibiting one or more enzymes in an essential metabolic pathway | SCHECHTER ALAN M | 2006-03-23 | — | — | US | disclosed |
| US-20050216976-A1 | Chimeric sequences for tissue-specific gene expression in plants | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2005-09-29 | — | — | US | disclosed |
| WO-2005070088-A2 | CHIMERIC SEQUENCES FOR TISSUE-SPECIFIC GENE EXPRESSION IN PLANTS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2005-08-04 | — | — | WO | disclosed |
| WO-2005049642-A2 | GENOME OF LEGIONELLA PNEUMOPHILA PARIS AND LENS STRAIN-DIAGNOSTIC AND EPIDEMIOLOGICAL APPLICATIONS | INSTITUT PASTEUR (FR) | 2005-06-02 | — | — | WO | disclosed |
| WO-2005001101-A1 | CONDITIONAL STERILITY IN PLANTS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2005-01-06 | — | — | WO | disclosed |
| CN-1500146-A | Genome of bifidobacterium | �Ʒ� | 2004-05-26 | — | — | CN | disclosed |
| US-6632636-B1 | Use of vectors, host cells and methods for producing Moraxella catarrhalis proteins, or portions thereof, for identification of diagnostic and therapeutic compositions | ELITRA PHARMACEUTICALS INC. | 2003-10-14 | — | — | US | disclosed |
| EP-1261630-A2 | BACTERIAL GENES AND PROTEINS THAT ARE ESSENTIAL FOR CELL VIABILITY AND THEIR USES | Bristol-Myers Squibb Company (US) | 2002-12-04 | — | — | EP | disclosed |
| WO-2001049721-A2 | BACTERIAL GENES AND PROTEINS THAT ARE ESSENTIAL FOR CELL VIABILITY AND THEIR USES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-07-12 | — | — | WO | disclosed |